Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates-Reference-Cited by-同舟云学术

Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates

Published:2023-03 Issue:2 Volume:28 Page:36-41
ISSN:2472-5552
Container-title:SLAS Discovery
language:en
Short-container-title:SLAS Discovery

Author:

Feodoroff Michaela^ORCID,Mikkonen Piia,Arjama Mariliina^ORCID,Murumägi Astrid,Kallioniemi Olli,Potdar Swapnil,Turunen Laura^ORCID,Pietiäinen Vilja^ORCID

Funder

Finnish Cultural Foundation

Cancer Foundation Finland

Academy of Finland

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference29 articles.

1. Screening out irrelevant cell-based models of disease;Horvath;Nat Rev Drug Discov,2016

2. Modeling physiological events in 2D vs. 3D cell culture;Duval;Physiology,2017

3. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors;Edmondson;Assay Drug Dev Technol,2014

4. Disease modeling in stem cell-derived 3D organoid systems;Dutta;Trends Mol Med,2017

5. Tumor organoids as a pre-clinical cancer model for drug discovery;Weeber;Cell Chem Biol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving high-resolution single-cell segmentation in convoluted cancer spheroids via Bayesian optimization and deep-learning;2024-09-10

2. Empowering High Throughput Screening of 3D Models: Automated Dispensing of Cervical and Endometrial Cancer Cells;2024-03-09

3. The challenge of making the right choice: patient avatars in the era of cancer immunotherapies;Frontiers in Immunology;2023-08-10

4. Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT);SLAS Discovery;2023-06

5. Protocols in drug discovery;SLAS Discovery;2023-03